Prevalence, Patterns, and Costs of Chinese Medicine Use Among Prostate Cancer Patients: A Population-Based Study in Taiwan

Abstract

Background. Taiwan's National Health Insurance (NHI) is a comprehensive and universal program, providing Western medicine (WM) and Chinese medicine (CM). This study aims to explore CM use among prostate cancer patients in NHI. Methods. A cross-section retrospective analysis was conducted using registration and claim data sets from the NHI Research Database. In 2007, 22 352 prostate cancer patients with 265 497 visits of CM and WM ambulatory services were identified. Patient demographics, patterns of therapies, and costs were analyzed. Results. In 2007, 592 prostate cancer patients (2.6%) had 4141 CM outpatient visits (7.0 on average). The median age was 73.9. The majority (90.5%) of CM users also used WM ambulatory services. About one third of CM outpatient services were provided by private clinics. The most frequently used CM therapies were Chinese herbal medication (93.6%), followed by acupuncture/traumatology manipulative therapies (7.0%). CM accounted for 0.2% expenditure ($87 500) and 1.6% visits of ambulatory services. The average cost per visit for WM was 6.3 times higher than that for CM ($133.6 vs $21). Conclusions. The prevalence and costs of insurance-covered CM among prostate cancer patients were low. Most prostate cancer patients did not use insurance-covered CM. The majority of CM users also used WM. CM appeared to play a complementary rather than an alternative role.

Prescription patterns of Chinese herbal products for menopausal syndrome: Analysis of a nationwide prescription database

“…This publicly available research database provides comprehensive data gathered under unrestricted access and is particularly valid for investigating TCM. A number of TCM studies have been published using this nationwide prescription database Chen et al, 2006Chen et al, , 2008aHsieh et al, 2008;Yang et al, 2009;Jong et al, 2010;Lin et al, 2010b).…”

Anti-cancer effect of ursolic acid activates apoptosis through ROCK/PTEN mediated mitochondrial translocation of cofilin-1 in prostate cancer

“…Previous studies have reported that Traditional Chinese Medicine (TCM) has effects on androgen-dependent and -independent prostate carcinoma (7)(8)(9). At present, there are seldom resources of TCM for the treatment of prostate carcinoma and the results of clinical and experimental studies are indispensable for further data regarding TCM therapy for the treatment of this disease (10).…”

Use of Acupuncture Among Patients with Prostate Cancer Covered by National Health Insurance in Taiwan: A Retrospective Population-Based Study

“…9,18,22 The current authors' previous cross-sectional study found the most frequently used Chinese medicine therapies among patients with prostate cancer were Chinese herbal medication (93.6% as shown by visits), followed by acupuncture/ traumatology manipulative therapies (7.0% as shown by visits). 23 However, the prevalence of acupuncture was not available because of data limitation. In this study, the prevalence of acupuncture use was much higher, ranging from 7.5% to 8.6% in each cross-sectional year and, overall, was 14.6% during [2002][2003][2004][2005][2006][2007][2008].…”